Financial News
Allied Motion Delivers Record Annual Gross Margin of 31.3% on Revenue of $503.0 Million in 2022
- Annual revenue up 25% to a record $503.0 million, driven by strong demand in Industrial and Aerospace & Defense markets and incremental sales from acquisitions; Organic growth was 12.0% for the year on a constant currency basis
- Fourth quarter revenue grew 35% to $131.1 million, with organic growth of 18.3% on a constant currency basis
- Annual gross margin expanded 130 basis points to a record 31.3% on higher volume and accretive acquisitions; Fourth quarter gross margin expanded 240 basis points to 31.1%
- Achieved annual net income of $17.4 million, or $1.09 per diluted share; Adjusted net income per share was $1.88, up 18% for the year
- Fourth quarter net income more than doubled to $3.7 million, or $0.23 per diluted share; Adjusted net income per share for the quarter was up 43% to $0.43
- Fourth quarter orders of $145.6 million drove a book-to-bill ratio of 1.1x and record backlog of $330.1 million at year-end
Allied Motion Technologies Inc. (Nasdaq: AMOT) (“Allied Motion” or “Company”), a designer and manufacturer of precision and specialty controlled motion products and solutions for the global market, today reported financial results for its fourth quarter and full year ended December 31, 2022. Results include all acquisitions completed during the fourth quarter of 2021 and in the second quarter of 2022.
“Our fourth quarter and full year results were strong and speak to the consistent and focused efforts of the entire Allied team to execute our strategy and deliver strong organic growth and create new growth opportunities through selective acquisitions,” commented Dick Warzala, Chairman and CEO. “The fourth quarter provided several highlights, which included impressive organic growth of 18%, the strengthening of our margin profile, and robust order levels which were broad-based across many of our targeted markets. For the year, we continued to demonstrate our ability to manage our business effectively despite the challenging macro conditions as we crossed a revenue milestone of more than $500 million and achieved our stated goal of gross margin expansion, reaching a record 31.3%.”
Mr. Warzala added, “While heightened levels of macroeconomic and geopolitical uncertainty remain, we believe we are in a strong position and are confident we can continue to execute our strategy by capitalizing on the many growth opportunities and positive underlying demand trends within our targeted markets. Equally important, we will continue to drive a higher level of continuous improvement in all areas of our business to enable margin expansion and long-term profitability.
“We entered 2023 with momentum on our side, a record level of backlog, significantly broadened scope of expertise and solutions, and an enhanced value proposition for our customers.”
Fourth Quarter 2022 Results (Narrative compares with prior-year period unless otherwise noted)
Revenue increased 35% to $131.1 million and reflected higher demand across each of the Company’s target markets, as well as incremental sales from acquisitions. Excluding the unfavorable impact of foreign currency exchange rate fluctuations on revenue of $6.7 million, revenue was up 42%, including organic growth of 18.3%. Sales to U.S. customers were 57% of total sales compared with 54% in the same period last year, with the balance of sales to customers primarily in Europe, Canada, and Asia-Pacific. See the attached table for a description of non-GAAP financial measures and reconciliation of revenue excluding foreign currency exchange rate fluctuations.
Aerospace & Defense revenue grew 197% due to organic growth, defense program timing, and incremental demand from acquisitions. Revenue from Industrial markets was up 46%, benefitting from strong end market demand within industrial automation, material handling and electronics. Vehicle market sales growth of 8% reflected higher demand from trucks, powersports and commercial automotive, while Medical markets were up slightly as surgical related markets and medical pumps offset lower pandemic related sales. The Distribution market, while a small component of total revenue, increased 22%.
Gross margin was 31.1%, up 240 basis points from the fourth quarter of 2021 as higher volume, margin accretive acquisitions, and pricing more than offset continued global supply chain disruptions, and rising material and labor costs.
Operating costs and expenses were 24.8% of revenue, up 30 basis points, which reflected an increase in engineering and development costs and intangible amortization expense, largely due to the second quarter M&A activity, partially offset by lower business development costs. As a result, operating income was $8.2 million compared with $4.0 million, and as a percent of revenue was 6.2%, up 210 basis points.
Net income increased to $3.7 million, or $0.23 per diluted share, from $1.6 million, or $0.11 per share, in the prior-year period. Adjusted net income, which excludes amortization of intangible assets related to acquisitions, business development costs and other non-recurring items, increased 58% to $6.9 million, or $0.43 per diluted share, compared with adjusted net income of $4.4 million, or $0.30 per diluted share. The effective tax rate was 27.7% compared with 53.9%, as the prior-year period included a $0.5 million valuation allowance of a deferred tax asset in a foreign jurisdiction. The Company expects its income tax rate for full year 2023 to be approximately 25% to 27%. See the attached tables for a description of non-GAAP financial measures and reconciliation table for Adjusted Net Income and Diluted Earnings per Share.
Earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses (“Adjusted EBITDA”) was $16.6 million, up $5.3 million, or 47%, from the year ago period. As a percent of sales, Adjusted EBITDA was 12.7%, up 100 basis points from the fourth quarter of 2021. The Company believes that, when used in conjunction with measures prepared in accordance with U.S. generally accepted accounting principles, Adjusted EBITDA, which is a non-GAAP measure, helps in the understanding of its operating performance. See the attached table for a description of non-GAAP financial measures and reconciliation table for Adjusted EBITDA.
Full Year 2022 Results (Narrative compares with prior-year period unless otherwise noted)
Revenue of $503.0 million increased $99.5 million, or 25%, reflecting strong demand in Industrial and Aerospace & Defense markets, including incremental sales from acquisitions. The impact of FX fluctuations was unfavorable by $22.3 million. On a constant currency basis, revenue was up 30% for the year, which included 12.0% organic growth. Sales to U.S. customers were 58% of total sales compared with 54% for 2021, with the balance of sales to customers primarily in Europe, Canada, and Asia-Pacific.
Gross margin was 31.3%, up 130 basis points, and reflected similar impacts as the fourth quarter of 2022. Operating costs and expenses as a percent of revenue were 25.0%, up 140 basis points largely due to M&A activity, which resulted in higher engineering and development costs, intangible amortization expense and business development costs. As a result, operating income was $31.7 million, or 6.3% of sales, compared with $26.0 million, or 6.4% of sales.
Net income was $17.4 million, or $1.09 per diluted share, compared with $24.1 million, or $1.66 per diluted share. The prior-year period included a net discrete tax benefit of $7.4 million recorded in the first quarter of 2021 relating to legislation enacted in New Zealand. Excluding the discrete tax benefit, amortization of intangible assets and other non-recurring items, adjusted net income was $30.0 million, or $1.88 per diluted share, compared with $23.2 million, or $1.60 per diluted share, in 2021. Adjusted EBITDA increased 31% to $65.5 million, and as a percent of sales was 13.0%, up 60 basis points.
Balance Sheet and Cash Flow Review
Cash and cash equivalents were $30.6 million compared with $22.5 million at year-end 2021. Cash provided by operating activities was $5.6 million for 2022, a decrease from the prior-year due to higher levels of inventory and working capital timing. Full year capital expenditures were $15.9 million and were largely focused on new customer projects. The Company expects 2023 capital expenditures to be approximately $18 million to $23 million.
Total debt was $235.5 million compared with $159.0 million at year-end 2021. The change largely reflected the funding used for the acquisitions completed during the second quarter of 2022 and a new finance lease during the first quarter of 2022 for a manufacturing facility expansion. Debt, net of cash, was $204.8 million, or 48.7% of net debt to capitalization.
Orders and Backlog Summary ($ in thousands)
Q4 2022 |
Q3 2022 |
Q2 2022 |
Q1 2022 |
Q4 2021 |
|||||||||||||
Orders |
$ |
145,564 |
$ |
126,158 |
$ |
139,209 |
$ |
155,295 |
$ |
114,891 |
|||||||
Backlog |
$ |
330,078 |
$ |
310,186 |
$ |
323,873 |
$ |
289,295 |
$ |
249,927 |
Fourth quarter orders increased 27% year-over-year and represented a book-to-bill ratio of 1.11x. Foreign currency translation had an unfavorable $12.5 million impact on fourth quarter orders compared with the prior-year period. The Company’s book-to-bill ratio for full year 2022 was 1.13x.
Backlog was up 6% from the sequential third quarter and increased 32% over the prior-year period to a record $330.1 million. The time to convert the majority of backlog to sales is approximately three to nine months.
Conference Call and Webcast
The Company will host a conference call and webcast on Wednesday, March 8, 2023 at 10:00 am ET. During the conference call, management will review the financial and operating results and discuss Allied Motion’s corporate strategy and outlook. A question and answer session will follow.
To listen to the live call, dial (201) 689-8263. In addition, the webcast and slide presentation may be found at: www.alliedmotion.com/investor-relations.
A telephonic replay will be available from 1:00 pm ET on the day of the call through Wednesday, March 15, 2023. To listen to the archived call, dial (412) 317-6671 and enter replay pin number 13735006 or access the webcast replay via the Company’s website. A transcript will also be posted to the website once available.
About Allied Motion Technologies Inc.
Allied Motion (Nasdaq: AMOT) designs, manufactures and sells precision controlled motion products and solutions used in a broad range of applications within the Industrial, Vehicle, Medical and Aerospace & Defense Markets. Headquartered in Amherst, NY, the Company has global operations and sells into markets across the United States, Canada, South America, Europe and Asia-Pacific.
Allied Motion is focused on controlled motion applications and is known worldwide for its expertise in electro-magnetic, mechanical, and electronic controlled motion technologies. Its products and solutions include nano precision positioning systems, servo control systems, motion controllers, digital servo amplifiers and drives, brushless servo, torque, and coreless motors, brush motors, integrated motor-drives, gear motors, gearing, incremental and absolute optical encoders, active (electronic) and passive (magnetic) filters for power quality and harmonic issues, lightweighting technologies, Industrial safety rated I/O Modules, Universal Industrial Communications Gateways and other controlled motion-related products.
The Company’s growth strategy is focused on being the controlled motion solutions leader in its selected target markets by leveraging its “technology/know how” to develop integrated precision solutions that utilize multiple Allied Motion technologies to “change the game” and create higher value solutions for its customers. The Company routinely posts news and other important information on its website at www.alliedmotion.com.
Safe Harbor Statement
The statements in this news release and in the Company’s March 8, 2023 conference call that relate to future plans, events or performance are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements. Examples of forward-looking statements include, among others, statements the Company makes regarding expected operating results, anticipated levels of capital expenditures, the Company’s belief that it has sufficient liquidity to fund its business operations, and expectations with respect to the conversion of backlog to sales. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company’s current beliefs, expectations and assumptions regarding the future of the Company’s business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, general economic and business conditions, conditions affecting the industries served by the Company and its subsidiaries, conditions affecting the Company's customers and suppliers, competitor responses to the Company's products and services, the overall market acceptance of such products and services, the pace of bookings relative to shipments, the ability to expand into new markets and geographic regions, the success in acquiring new business, the impact of changes in income tax rates or policies, the severity, magnitude and duration of the COVID-19 pandemic, including impacts of the pandemic and of businesses’ and governments’ responses to the pandemic on our operations and personnel, and on commercial activity and demand across our and our customers’ businesses, and on global supply chains; our inability to predict the extent to which the COVID-19 pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations, financial position, the prices of our securities and the achievement of our strategic objectives, the ability to attract and retain qualified personnel, the ability to successfully integrate an acquired business into our business model without substantial costs, delays, or problems, and other factors disclosed in the Company's periodic reports filed with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made. New risks and uncertainties arise over time, and it is not possible for us to predict the occurrence of those matters or the manner in which they may affect us. The Company has no obligation or intent to release publicly any revisions to any forward looking statements, whether as a result of new information, future events, or otherwise.
FINANCIAL TABLES FOLLOW
ALLIED MOTION TECHNOLOGIES INC. CONSOLIDATED STATEMENTS OF INCOME (In thousands, except per share data) (Unaudited) |
||||||||||||
For the three months ended |
For the year ended |
|||||||||||
December 31, |
December 31, |
|||||||||||
|
2022 |
2021 |
|
2022 |
|
2021 |
||||||
Revenue |
$ |
131,076 |
$ |
96,793 |
$ |
502,988 |
$ |
403,516 |
||||
Cost of goods sold |
|
90,348 |
|
69,043 |
|
345,729 |
|
282,460 |
||||
Gross profit |
|
40,728 |
|
27,750 |
|
157,259 |
|
121,056 |
||||
Operating costs and expenses: |
|
|
||||||||||
Selling |
|
5,541 |
|
4,270 |
|
21,877 |
|
17,249 |
||||
General and administrative |
|
13,438 |
|
9,870 |
|
50,677 |
|
42,419 |
||||
Engineering and development |
|
9,682 |
|
6,851 |
|
38,561 |
|
27,818 |
||||
Business development |
|
855 |
|
1,031 |
|
3,319 |
|
1,299 |
||||
Amortization of intangible assets |
|
3,036 |
|
1,718 |
|
11,169 |
|
6,245 |
||||
Total operating costs and expenses |
|
32,552 |
|
23,740 |
|
125,603 |
|
95,030 |
||||
Operating income |
|
8,176 |
|
4,010 |
|
31,656 |
|
26,026 |
||||
Other expense, net: |
|
|
||||||||||
Interest expense |
|
2,792 |
|
791 |
|
7,692 |
|
3,236 |
||||
Other expense (income), net |
|
274 |
|
(165) |
|
283 |
|
(323) |
||||
Total other expense, net |
|
3,066 |
|
626 |
|
7,975 |
|
2,913 |
||||
Income before income taxes |
|
5,110 |
|
3,384 |
|
23,681 |
|
23,113 |
||||
Income tax (provision) benefit |
|
(1,414) |
|
(1,823) |
|
(6,292) |
|
981 |
||||
Net income |
$ |
3,696 |
$ |
1,561 |
$ |
17,389 |
$ |
24,094 |
||||
Basic earnings per share: |
|
|
||||||||||
Earnings per share |
$ |
0.24 |
$ |
0.11 |
$ |
1.13 |
$ |
1.67 |
||||
Basic weighted average common shares |
|
15,671 |
|
14,527 |
|
15,448 |
|
14,413 |
||||
Diluted earnings per share: |
|
|
||||||||||
Earnings per share |
$ |
0.23 |
$ |
0.11 |
$ |
1.09 |
$ |
1.66 |
||||
Diluted weighted average common shares |
|
16,145 |
|
14,632 |
|
15,951 |
|
14,517 |
ALLIED MOTION TECHNOLOGIES INC. CONSOLIDATED BALANCE SHEETS (In thousands, except per share data) |
||||||
December 31, |
||||||
|
2022 |
|
2021 |
|||
Assets |
||||||
Current assets: |
||||||
Cash and cash equivalents |
$ |
30,614 |
$ |
22,463 |
||
Trade receivables, net of provision for credit losses of $1,192 and $506 at December 31, 2022 and December 31, 2021, respectively |
76,213 |
51,239 |
||||
Inventories |
|
117,108 |
|
89,733 |
||
Prepaid expenses and other assets |
|
12,072 |
|
12,522 |
||
Total current assets |
|
236,007 |
|
175,957 |
||
Property, plant, and equipment, net |
|
68,640 |
|
56,983 |
||
Deferred income taxes |
|
4,199 |
|
5,321 |
||
Intangible assets, net |
|
119,075 |
|
103,786 |
||
Goodwill |
|
126,366 |
|
106,633 |
||
Operating lease assets |
22,807 |
16,983 |
||||
Other long-term assets |
|
11,253 |
|
5,122 |
||
Total Assets |
$ |
588,347 |
$ |
470,785 |
||
Liabilities and Stockholders’ Equity |
||||||
Current liabilities: |
||||||
Accounts payable |
$ |
39,467 |
$ |
36,714 |
||
Accrued liabilities |
|
48,121 |
|
41,656 |
||
Total current liabilities |
|
87,588 |
|
78,370 |
||
Long-term debt |
|
235,454 |
|
158,960 |
||
Deferred income taxes |
|
6,262 |
|
5,040 |
||
Pension and post-retirement obligations |
|
3,009 |
|
3,932 |
||
Operating lease liabilities |
18,795 |
12,792 |
||||
Other long-term liabilities |
|
21,774 |
23,929 |
|||
Total liabilities |
|
372,882 |
|
283,023 |
||
Stockholders’ Equity: |
||||||
Common stock, no par value, authorized 50,000 shares; 15,978 and 15,361 shares issued and outstanding at December 31, 2022 and December 31, 2021, respectively |
|
83,852 |
|
68,097 |
||
Preferred stock, par value $1.00 per share, authorized 5,000 shares; no shares issued or outstanding |
|
— |
|
— |
||
Retained earnings |
|
143,576 |
|
127,757 |
||
Accumulated other comprehensive loss |
|
(11,963) |
|
(8,092) |
||
Total stockholders’ equity |
|
215,465 |
|
187,762 |
||
Total Liabilities and Stockholders’ Equity |
$ |
588,347 |
$ |
470,785 |
ALLIED MOTION TECHNOLOGIES INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (In thousands) |
||||||
For the year ended |
||||||
December 31, |
December 31, |
|||||
|
2022 |
|
2021 |
|||
Cash Flows From Operating Activities: |
||||||
Net income |
$ |
17,389 |
$ |
24,094 |
||
Adjustments to reconcile net income to net cash provided by operating activities |
||||||
Depreciation and amortization |
|
25,486 |
|
18,107 |
||
Deferred income taxes |
|
(3,722) |
|
(6,135) |
||
Provision for excess and obsolete inventory |
|
|
1,628 |
|
|
534 |
Stock-based compensation expense |
5,073 |
4,161 |
||||
Debt issue cost amortization recorded in interest expense |
202 |
141 |
||||
Other |
|
393 |
|
415 |
||
Changes in operating assets and liabilities, net of acquisition: |
||||||
Trade receivables |
|
(22,202) |
|
(170) |
||
Inventories |
|
(27,800) |
|
(22,874) |
||
Prepaid expenses and other assets |
|
887 |
|
(3,670) |
||
Accounts payable |
|
2,791 |
|
8,293 |
||
Accrued liabilities |
|
5,471 |
|
2,506 |
||
Net cash provided by operating activities |
|
5,596 |
|
25,402 |
||
Cash Flows From Investing Activities: |
||||||
Consideration paid for acquisitions, net of cash acquired |
|
(44,101) |
|
(47,254) |
||
Purchase of property and equipment |
(15,910) |
(13,716) |
||||
Net cash used in investing activities |
|
(60,011) |
|
(60,970) |
||
Cash Flows From Financing Activities: |
||||||
Proceeds from issuance of long-term debt |
|
74,731 |
|
51,379 |
||
Principal payments of long-term debt and finance lease obligations |
(7,585) |
(12,248) |
||||
Payment of debt issuance costs |
|
(391) |
|
— |
||
Dividends paid to stockholders |
|
(1,536) |
|
(1,371) |
||
Tax withholdings related to net share settlements of restricted stock |
|
(1,614) |
|
(1,928) |
||
Net cash provided by financing activities |
|
63,605 |
|
35,832 |
||
Effect of foreign exchange rate changes on cash |
|
(1,039) |
|
(932) |
||
Net decrease in cash and cash equivalents |
|
8,151 |
|
(668) |
||
Cash and cash equivalents at beginning of period |
|
22,463 |
|
23,131 |
||
Cash and cash equivalents at end of period |
$ |
30,614 |
$ |
22,463 |
ALLIED MOTION TECHNOLOGIES INC.
Reconciliation of Non-GAAP Financial Measures
(In thousands)
(Unaudited)
In addition to reporting revenue and net income, which are U.S. generally accepted accounting principle (“GAAP”) measures, the Company presents Revenue excluding foreign currency exchange rate impacts, and EBITDA and Adjusted EBITDA (earnings before interest, income taxes, depreciation and amortization, stock-based compensation expense, business development costs, and foreign currency gains/losses), which are non-GAAP measures.
The Company believes that Revenue excluding foreign currency exchange rate impacts is a useful measure in analyzing organic sales results. The Company excludes the effect of currency translation from revenue for this measure because currency translation is not under management’s control, is subject to volatility and can obscure underlying business trends. The portion of revenue attributable to currency translation is calculated as the difference between the current period revenue and the current period revenue after applying foreign exchange rates from the prior period.
The Company believes EBITDA and Adjusted EBITDA are often a useful measure of a Company’s operating performance and are a significant basis used by the Company’s management to evaluate and compare the core operating performance of its business from period to period by removing the impact of the capital structure (interest), tangible and intangible asset base (depreciation and amortization), taxes, stock-based compensation expense, business development costs, foreign currency gains/losses on short-term assets and liabilities, and other items that are not indicative of the Company’s core operating performance. EBITDA and Adjusted EBITDA do not represent and should not be considered as an alternative to net income, operating income, net cash provided by operating activities or any other measure for determining operating performance or liquidity that is calculated in accordance with GAAP.
The Company’s calculation of Revenue excluding foreign currency exchange impacts for the three and twelve months ended December 31, 2022 is as follows:
Three Months Ended |
|
Twelve Months Ended |
||
December 31, 2022 |
|
December 31, 2022 |
||
Revenue as reported |
$ 131,076 |
|
$ 502,988 |
|
Currency impact |
6,686 |
|
22,263 |
|
Revenue excluding foreign currency exchange impacts |
$ 137,762 |
|
$ 525,251 |
The Company’s calculation of Adjusted EBITDA for the three and twelve months ended December 31, 2022 and 2021 is as follows:
Three Months Ended |
Twelve Months Ended |
|||
December 31, |
December 31, |
|||
2022 |
2021 |
2022 |
2021 |
|
Net income |
$ 3,696 |
$ 1,561 |
$ 17,389 |
$ 24,094 |
Interest expense |
2,792 |
791 |
7,692 |
3,236 |
Provision (benefit) for income tax |
1,414 |
1,823 |
6,292 |
(981) |
Depreciation and amortization |
6,264 |
4,990 |
25,486 |
18,307 |
EBITDA |
14,166 |
9,165 |
56,859 |
44,656 |
Stock compensation expense |
1,321 |
1,060 |
5,073 |
4,161 |
Foreign currency loss |
244 |
63 |
298 |
21 |
Business development costs |
855 |
1,032 |
3,319 |
1,299 |
Adjusted EBITDA |
$ 16,586 |
$ 11,320 |
$ 65,549 |
$ 50,137 |
ALLIED MOTION TECHNOLOGIES INC.
Reconciliation of GAAP Net Income and Diluted Earnings per Share to
Non-GAAP Adjusted Net Income and Diluted Earnings per Share
(In thousands, except per share data)
(Unaudited)
The Company’s calculation of Adjusted net income and Adjusted diluted earnings per share for the three and twelve months ended December 31, 2022 and 2021 is as follows:
Three Months Ended |
||||||||||||
December 31, |
||||||||||||
2022 |
Per diluted
|
2021 |
Per diluted
|
|||||||||
Net income as reported |
$ 3,696 |
$ 0.23 |
$ 1,561 |
$ 0.11 |
||||||||
Non-GAAP adjustments, net of tax |
||||||||||||
Income tax valuation allowance |
|
- |
- |
|
506 |
0.03 |
|
|||||
Amortization of intangible assets - net |
|
2,395 |
0.15 |
|
1,470 |
0.10 |
|
|||||
Foreign currency gain/ loss - net |
|
187 |
0.01 |
|
48 |
- |
|
|||||
Business development costs - net |
655 |
0.04 |
790 |
0.05 |
||||||||
Adjusted net income and diluted EPS |
$ 6,933 |
$ 0.43 |
$ 4,375 |
$ 0.30 |
||||||||
Weighted average diluted shares outstanding |
16,145 |
14,632 |
Twelve Months Ended |
||||||||||||
December 31, |
||||||||||||
2022 |
Per diluted
|
2021 |
Per diluted
|
|||||||||
Net income as reported |
$ 17,389 |
$ 1.09 |
$ 24,094 |
$ 1.66 |
||||||||
Non-GAAP adjustments, net of tax |
||||||||||||
Income tax valuation allowance |
- |
- |
|
506 |
0.03 |
|
||||||
Income tax benefit |
- |
- |
|
(7,373) |
(0.51) |
|
||||||
Amortization of intangible assets - net |
|
9,812 |
0.62 |
|
4,938 |
0.34 |
|
|||||
Foreign currency gain/ loss - net |
|
228 |
0.01 |
|
18 |
0.00 |
|
|||||
Business development costs - net |
2,542 |
0.16 |
998 |
0.07 |
||||||||
Adjusted net income and diluted EPS |
$ 29,971 |
$ 1.88 |
$ 23,181 |
$ 1.60 |
||||||||
Weighted average diluted shares outstanding |
15,951 |
14,517 |
Adjusted net income and diluted EPS are defined as net income as reported, adjusted for certain items, including amortization of intangible assets and unusual non-recurring items. Adjusted net income and diluted EPS are not a measure determined in accordance with GAAP in the United States, and may not be comparable to the measure as used by other companies. Nevertheless, the Company believes that providing non-GAAP information, such as adjusted net income and diluted EPS are important for investors and other readers of the Company’s financial statements and assists in understanding the comparison of the current quarter’s and current year’s net income and diluted EPS to the historical periods’ net income and diluted EPS.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230307005961/en/
Contacts
Investor Contacts:
Deborah K. Pawlowski / Craig P. Mychajluk
Kei Advisors LLC
716-843-3908 / 716-843-3832
dpawlowski@keiadvisors.com / cmychajluk@keiadvisors.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.